Literature DB >> 23354005

Development of antimicrobial synbiotics using potentially-probiotic faecal isolates of Lactobacillus fermentum and Bifidobacterium longum.

Eleni Likotrafiti1, Kieran M Tuohy, Glenn R Gibson, Robert A Rastall.   

Abstract

The aims of the present study were to investigate in vitro the antimicrobial activity of Lactobacillus fermentum and Bifidobacterium longum, isolated from faeces of healthy elderly individuals, against enterohaemorrhagic Escherichia coli (E. coli O157:H7) and enteropathogenic E. coli (E. coli O86), to determine the capability of the selected strains to tolerate acid and bile in vitro, to select suitable carbohydrates in order to enhance the growth and maximise antimicrobial activity of the putative probiotic organisms and examine the adhesion properties of the synbiotics. Antimicrobial activity of the putative probiotics and synbiotics was investigated by a microtitre method using cell-free culture supernatants (CFCS). Results of the antimicrobial assay showed that both putative probiotic strains produced compounds at pH 5 that lead to higher lag phases of both E. coli O157:H7 and E. coli O86. When half the quantity of cell-free culture supernatants of both probiotic strains was used at pH 5, B. longum maintained the same antimicrobial effect against both strains of E. coli, whereas L. fermentum lead to a higher lag phase of E. coli O86 only. Neutralization of the culture supernatants with alkali reduced the antimicrobial effect with only cell-free supernatant of L. fermentum causing lower maximum growth rates of E. coli O157:H7 and E. coli O86. L. fermentum appeared to be acid tolerant whereas B. longum was more susceptible to acid and both isolates were bile tolerant. A short chain fructooligosaccharide (scFOS) and an isomalto-oligosaccharide (IMO) proved to be the most effective substrates, enhancing antimicrobial activity for L. fermentum and B. longum respectively. The adhesion of the synbiotic combinations showed that L. fermentum, exhibited higher percentage of adhesion when grown on glucose and as a synbiotic combination with scFOS whereas B. longum exhibited lowest percentage of adhesion when grown on both glucose and IMO.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354005     DOI: 10.1016/j.anaerobe.2013.01.002

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  5 in total

Review 1.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

2.  Effect of Lactobacillus rhamnosus NCDC 298 with FOS in Combination on Viability and Toxin Production of Enterotoxigenic Escherichia coli.

Authors:  Santosh Anand; Surajit Mandal; Sudhir Kumar Tomar
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

Review 3.  Management of STEC Gastroenteritis: Is There a Role for Probiotics?

Authors:  Mario Giordano; Maria Elisabetta Baldassarre; Viviana Palmieri; Diletta D Torres; Vincenza Carbone; Luisa Santangelo; Federico Gentile; Raffaella Panza; Federica Di Mauro; Manuela Capozza; Antonio Di Mauro; Nicola Laforgia
Journal:  Int J Environ Res Public Health       Date:  2019-05-12       Impact factor: 3.390

4.  In Vitro Probiotic Properties and DNA Protection Activity of Yeast and Lactic Acid Bacteria Isolated from A Honey-Based Kefir Beverage.

Authors:  Bruna de Oliveira Coelho; Fernanda Fiorda-Mello; Gilberto V de Melo Pereira; Vanete Thomaz-Soccol; Sudip K Rakshit; Júlio Cesar de Carvalho; Carlos Ricardo Soccol
Journal:  Foods       Date:  2019-10-12

5.  Screening of indigenous oxalate degrading lactic acid bacteria from human faeces and South Indian fermented foods: assessment of probiotic potential.

Authors:  Sivasamy Gomathi; Ponnusamy Sasikumar; Kolandaswamy Anbazhagan; Sundaresan Sasikumar; Murugan Kavitha; M S Selvi; Govindan Sadasivam Selvam
Journal:  ScientificWorldJournal       Date:  2014-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.